Chen, Yingrong http://orcid.org/0000-0003-2901-0600
Ye, Libing
Mei, Jue
Tian, Mengli
Xu, Min
Jin, Qiuyue
Yu, Xiang
Yang, Shuixin http://orcid.org/0000-0001-7190-5251
Wang, Jie
Clinical trials referenced in this document:
Documents that mention this clinical trial
Pharmacokinetics and Bioequivalence of Two Formulations of Azithromycin Tablets: A Randomized, Single-Dose, Three-Period, Crossover Study in Healthy Chinese Volunteers Under Fasting and Fed Conditions
https://doi.org/10.1007/s40268-024-00464-8
Funding for this research was provided by:
Shijiazhuang No.4 Pharmaceutical Co., Ltd.,
Public Welfare Application Research Project of Huzhou Technology Plan (2021GZ71)
Youth Talent Program of Huzhou Central Hospital (2020YC12)
Article History
Accepted: 21 April 2024
First Online: 30 May 2024
Declarations
:
: This work was funded by Shijiazhuang No.4 Pharmaceutical Co., Ltd., Hebei, China, Public Welfare Application Research Project of Huzhou Technology Plan (Grant number 2021GZ71) and Youth Talent Program of Huzhou Central Hospital (Grant number 2020YC12).
: JW is an employee of Shijiazhuang No.4 Pharmaceutical Co., Ltd. YRC, LBY, JM, MLT, MX, QYJ, XY and SXY report no conflicts of interest.
: The study was approved by the Ethics Committee at Huzhou Central Hospital on December 09, 2020 (Approval No. 202112015-01). The written informed consents was obtained from all participants.
: All study participants provided written informed consent.
: All researchers, participants, institutions, and sponsors consented to the submission of this report to the journal.
: The datasets generated during and/or analyzed during the current study are available from the corresponding author on reasonable request.
: Not applicable.
: The study was conceptualized and designed by SXY and JW. YRC analyzed the data and wrote the article. Material preparation and data collection were performed by LBY, JM, MLT, MX, QYJ and XY. All authors read and approved the final manuscript.